# FDA Inspection 1245571 - Siegfried (Nantong) Pharmaceuticals Co., Ltd. - July 05, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/siegfried-nantong-pharmaceuticals-co-ltd/2176325a-e6e7-48a3-b49f-bc5011497ad7/
Source feed: FDA_Inspections

> FDA Inspection 1245571 for Siegfried (Nantong) Pharmaceuticals Co., Ltd. on July 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245571
- Company Name: Siegfried (Nantong) Pharmaceuticals Co., Ltd.
- Inspection Date: 2024-07-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1245571 - 2024-07-05](https://www.globalkeysolutions.net/api/records/fda_inspections/siegfried-nantong-pharmaceuticals-co-ltd/1c62e27b-e4c7-4d9c-b1f7-08e6d1a935ad/)
- [FDA Inspection 1103042 - 2019-08-16](https://www.globalkeysolutions.net/api/records/fda_inspections/siegfried-nantong-pharmaceuticals-co-ltd/24a9b962-8636-43f7-a48c-ab8da5cd6b4f/)

Company: https://www.globalkeysolutions.net/companies/siegfried-nantong-pharmaceuticals-co-ltd/0f735555-bd37-452f-b5f5-a205454957c1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c